Is there a new global health threat? Fungal superbugs spread panic with climate change expanding its reach

A new global health threat is emerging as drug-resistant fungal infections such as Aspergillus fumigatus and Coccidioides are spreading, driven by climate change. Infecting millions, these infections are difficult to treat because fungi are geneti...

A new global health threat is emerging—drug-resistant fungal infections. These microscopic fungal spores like Coccidioides, responsible for valley fever, are infecting people who inhale them from air or soil, even in their own backyards.

Torrence Irvin from California became critically ill after he unknowingly inhaled the spores. Doctors took nearly a year to correctly diagnose him. However, by that time, he had lost a significant amount of weight and nearly died.

As per a CNN report, another survivor Rob Purdie contracted fungal meningitis after he inhaled spores while gardening and now depends on lifelong toxic treatments.


Another dangerous fungus causes lung issues

Aspergillus fumigatus, another dangerous fungus, could spread across Europe, Asia, and the Americas, and will affect millions of vulnerable individuals. This fungus, a study said, thrives in warm, damp environments and could potentially infect people by invading their lungs, particularly those who have underlying health issues like asthma, cystic fibrosis, or weakened immune systems.

WHO lists 19 fungal species as urgent priorities

The World Health Organisation (WHO) reportedly has enlisted nearly 6.5 million invasive fungal infections. This, they said, results in 3.8 million deaths globally each year and the numbers are climbing due to increasing drug resistance.

Also Read: Aaron Rodgers speculation gains momentum after Pittsburgh Steelers trade George Pickens to Dallas Cowboys
ADVERTISEMENT

They listed 19 fungal species under urgent priorities for new drug development, among which Aspergillus fumigatus is one. Other dangerous species include Cryptococcus neoformans (deadly meningitis), Candida auris (highly drug-resistant hospital infections) and Candida albicans (common yeast that can become invasive).

The CNN report stated that developing antifungal drugs is especially challenging since fungi are genetically closer to humans than bacteria. This means, the treatments can harm human cells, which could result in kidney failure, liver damage, or other severe side effects.

Dr Neil Clancy, an infectious disease specialist and associate professor of medicine at University of Pittsburgh, told CNN that if an antifungal drug is being made, it is crucial to come up with formulations that will not harm genes and human proteins.

Climate change could exacerbate the spread

Experts have noted that changing climate patterns, wildfires, and dust storms likely expand the fungi’s geographic reach. Reportedly, cases of Coccidioides infection have been reported in over 20 US states, including regions which previously were unaffected.
ADVERTISEMENT

The study on Aspergillus fumigatus stated it could expand across an additional 77 per cent of global territory by 2100 as climate change is accelerated. Researchers have estimated that 9 million people in Europe alone could be exposed to infection risks if fungus takes hold.

Reportedly, the fungus can grow rapidly in compost at high temperatures and can survive the human body’s internal heat of 37°C. It was also found thriving in extreme environments like Chernobyl’s nuclear reactors.
ADVERTISEMENT

Urgent need for antifungal innovation

Experimental drugs like Olorofim offer hope, however, experts have warned that limited specialist access and lack of public awareness could leave many patients untreated or misdiagnosed. More research, better treatments, and physician training are urgently needed to confront this growing fungal superbug threat, stated the CNN report.

Professor Elaine Bignell, co-director at the MRC Centre for Medical Mycology at Exeter University, said that the development of new antifungal treatments has been slow. One key reason, as per an NDTV report, is financial unattractiveness of investing in antifungal medicines.

Reportedly, the antifungal medicines are costly to develop and often spotted as less profitable compared to others in drug market.

FAQs:

Q1: What are drug-resistant fungal infections?
They are fungal infections that no longer react to usual antifungal treatment, so they are more difficult to treat and are possibly fatal.

Q2: Which fungi are the greatest threats?
WHO includes species such as Aspergillus fumigatus, Candida auris, Cryptococcus neoformans, and Coccidioides among the most lethal ones.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › US News › Is there a new global health threat? Fungal superbugs spread panic with climate change expanding its reach
Text Size:AAA
Success
This article has been saved

*

+